Susceptibility to vaccinia virus infection and spread in mice is determined by age at infection, allergen sensitization and mast cell status

International Archives of Allergy and Immunology

Volumn 158, Issue 2, 2012, Pages 196-205

  Domenico, Joanne ^a   Lucas, Joseph J ^a   Fujita, Mayumi ^b   Gelfand, Erwin W ^a  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Allergen sensitization; Eczema vaccinatum; Mast cells; Neutrophils; Vaccinia virus

Indexed keywords

CATHELICIDIN; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; OVALBUMIN; VIRUS DNA;

ADOPTIVE TRANSFER; AGE; ALLERGENICITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ECZEMA; ECZEMA VACCINATUM; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION RISK; INFECTION SENSITIVITY; INOCULATION; MAST CELL; MOUSE; NONHUMAN; POXVIRUS INFECTION; PRIORITY JOURNAL; SENSITIZATION; VACCINATION REACTION; VACCINIA VIRUS; VACCINIA VIRUS INFECTION; WILD TYPE;

ADOPTIVE TRANSFER; AGE FACTORS; ANIMALS; BONE MARROW CELLS; CATHELICIDINS; DERMATITIS, ATOPIC; IMMUNIZATION; KAPOSI VARICELLIFORM ERUPTION; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; VACCINIA; VACCINIA VIRUS;

EID: 84856140894     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000330647     Document Type: Article

References (46)

1. Esposito JJ, Fenner F: Poxviruses; in Knipe DM, Howley PM (eds): Fields Virology. Philadelphia, Lippincott Williams & Wilkins, 2001, pp 2885-2922.
2. World Health Organization: Declaration of global eradication of smallpox. Wkly Epidemiol Rec 1980; 55: 145.
3. Artenstein AW, Grabenstein JD: Smallpox vaccines for biodefense: need and feasibility. Expert Rev Vaccines 2008; 7: 1225-1227.
4. Grabenstein JD, Winkenwerder W: US military smallpox vaccination program experience. JAMA 2003; 289: 3278-3282. (Pubitemid 37430081)
5. Rotz LD, Dotson DA, Damon IK, Becher JA: Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2001; 50: 1-43.
6. Engler RJ, Kenner J, Leung DYM: Smallpox vaccination: risk considerations for patients with atopic dermatitis. J Allergy Clin Immunol 2002; 110: 357-365.
7. Wollenberg A, Engler R: Smallpox, vaccination and adverse reactions to smallpox vaccine. Curr Opin Allergy Clin Immunol 2004; 4: 271-275. (Pubitemid 39006841)
8. Neff, JM, Levine RH, Lane JM, Ager EA, Moore H, Rosenstein BJ, Millar JD, Henderson DA: Complications of smallpox vaccination: USA 1963. II. Results obtained by four statewide surveys. Pediatrics 1967; 39: 916-923.
9. Lane JM, Ruben FL, Neff JM, Millar JD: Complications of smallpox vaccination vaccination, 1968: national surveillance in the USA. N Engl J Med 1969; 281: 1201-1208.
10. Lane JM, Ruben FL, Neff JM, Millar JD: Complications of smallpox vaccination, 1968: results of ten statewide surveys. J Infect Dis 1970; 123: 303-309.
11. Laughter D, Istvan JA, Tofte SJ, Hanifin JM: The prevalence of atopic dermatitis in Oregon schoolchildren. J Am Acad Dermatol 2000; 43: 649-655.
12. Boguniewicz M, Leung DYM: Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol 2010; 125: 4-13.
13. Leung DYM, Bieber T: Atopic dermatitis. Lancet 2003; 361: 151-160.
14. Ong PY, Ohtake T, Brandt C, Strickland I, Bogniewicz M, Ganz T, Gallo RL, Leung DYM: Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347: 1151-1160.
15. Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF, Darst MA, Gao B, Boguniewicz M, Travers JB, Leung DYM: Cytokine milieu of atopic dermatitis, as opposed to psoriasis, skin prevents induction of innate immune response genes. J Immunol 2003; 171: 3262-3269. (Pubitemid 37093553)
16. Howell MD: The role of human beta defensins and cathelicidins in atopic dermatitis. Curr Opin Allergy Clin Immunol 2007; 7: 413-417.
17. Howell MD, Jones JF, Kisich KO, Streib JE, Gallo RL, Leung DYM: Selective killing of vaccinia virus by LL-37: implications for Eczema vaccinatum. J Immunol 2004; 172: 1763-1767. (Pubitemid 38116824)
18. Howell MD, Streib JE, Leung DYM: Antiviral activity of human β-defensin 3 against vaccinia virus. J Allergy Clin Immunol 2007; 119: 1022-1025. (Pubitemid 46527837)
19. Ballardini N, Johansson C, Lilja G, Lindh M, Linde Y, Scheynius A, Agerberth B: Enhanced expression of the antimicrobial peptide LL-37 in lesional skin of adults with atopic eczema. Br J Dermatol 2009; 161: 40-47.
20. Glaser R, Meyer-Hoffert U, Harder J, Cordes J, Wittersheim M, Kobliaskova J, Folster-Holst R, Proksch E, Schroder JM, Schwarz T: The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption. J Invest Dermatol 2009; 129: 641-649.
21. Harder J, Dressel S, Wittersheim M, Cordes J, Meyer-Hoffert U, Mrowietz U, Folster- Holst R, Proksch E, Schroder J, Schwarz T, Glaser T: Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury. J Invest Dermatol 2010; 130: 1355-1364.
22. Kawakami T, Ando T, Kiura M, Wilson BS, Kawakami Y: Mast cells in atopic dermatitis. Curr Opin Immunol 2009; 21: 666-678.
23. Di Nardo A, Vitiello A, Gallo RL: Mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol 2003; 170: 2274-2278. (Pubitemid 36245611)
24. Howell MD, Gallo RL, Boguniewicz M, Jones J, Wong C, Streib JE, Leung DYM: Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 2006; 24: 341-348.
25. Earl PL, Cooper N, Wyatt L, Moss B, Carroll MW: Preparation of cell cultures and vaccinia virus stocks; in Current Protocols in Molecular Biology, Supplement 43. Hoboken, John Wiley, 1968, pp 16.16.1-16.16.13.
26. Duttlinger R, Manova K, Chu TY, Gyssler C, Zelenetz AD, Bachvarova RF, Besmer P: Wsash affects positive and negative elements controlling c-kit expression: ectopic c-kit expression at site of kit-ligand expression affects melanogenesis. Development 1993; 118: 705-717. (Pubitemid 23232779)
27. Grimbaldeston MA, Chen C, Piliponsky AM, Tsai M, Tam A, Galli SJ: Mast cell-deficient W-sash c-kit mutant K itW -sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 2005; 167: 835-848. (Pubitemid 41216366)
28. Gallo RL, Kim KJ, Bemfield M, Kozak CA, Zanetti M, Merluzzi L, Gennaro R: Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J Biol Chem 1997; 272: 13088-13093. (Pubitemid 27216731)
29. Taube C, Wei X, Joetham A, Takeda K, Loader J, Miyahara N, Kodama T, Swasey CH, Shultz LD, Donaldson DD, Hamelmann E, Dakhama A, Gelfand EW: Mast cells, Fc epsilon RI and IL-13 are required for development of airway hyperresponsivneness following aerosolized allergen exposure in the absence of adjuvant. J Immunol 2004; 172: 6398-6406. (Pubitemid 38621249)
30. Li G, Domenico J, Jia Y, Lucas JJ, Gelfand EW: NF-κB-dependent induction of cathelicidin-related anitmicrobial peptide in murine mast cells by lipopolysaccharide. Intl Arch Allergy Immunol 2009; 150: 122-132.
31. Ishizuka T, Chayama K, Takeda K, Hamelmann E, Terada N, Keller GM, Johnson GL, Gelfand EW: Mitogen-activated protein kinase activation through Fcε receptor I and stem cell factor receptor is differentially regulated by phophotidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells. J Immunol 1999; 162: 2087-2094. (Pubitemid 29288829)
32. -/-mice leads to defective immunity and impaired clearance of vaccinia virus. J Allergy Clin Immunol 2007; 119: 671-679.
33. Fernandez MA, Puttur FK, Wang YM, Howden W, Alexander SI, Jones CA: T regulatory cells contribute to the attenuated primary CD8+ and CD4+ T cell responses to herpes simplex virus type 2 in neonatal mice. J Immunol 2008; 180: 1556-1564.
34. Dakhama A, Park JW, Taube C, Joetham A, Balhorn A, Miyahara N, Takeda K, Gelfand EW: The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production. J Immunol 2005; 175: 1876-1883. (Pubitemid 41023094)
35. Zanetti M: The role of cathelicidins in the innate host defenses of mammals. Curr Issues Mol Biol 2005; 7: 179-196.
36. Oyoshi MK, Elkhal A, Kumar L, Scott JE, Koduru S, He R, Leung DYM, Howell MD, Oettgen HC, Murphy GF, Geha RS: Vaccinia virus inoculation in sites of allergic skin inflammation elicits a vigorous cutaneous IL- 17 response. Proc Natl Acad Sci USA 2009; 106: 14954-14959.
37. Kawakami, Y, Tomimori Y, Yumoto K, Hasegawa S, Ando T, Tagaya Y, Crotty S, Kawakami T: Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum. J Exp Med 2009; 206: 1219-1225.
38. Barton D, HogenEsch H, Weih F: Mice lacking the transcription factor RelB develop T cell-dependent skin lesions similar to human atopic dermatitis. Eur J Immunol 2000; 30: 2323-2332.
39. Beck, LA, Boguniewicz M, Hata T, Schneider LC, Hanifin J, Gallo R, Paller AS, Lieff S, Reese J, Zaccaro D, Milgrom H, Barnes KC, Leung DYM: Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. J Allergy Clin Immunol 2009; 124: 260-269.
40. Jeong CW, Ahn KS, Rho NK, Park YD, Lee DY, Lee JH, Lee ES, Yang JM: Differential in vivo cytokine mRNA expression in lesional skin of intrinsic vs. extrinsic atopic dermatitis patients using semiquantitative RT-PCR. Clin Exp Allergy 2003; 33: 1717-1724.
41. Leung DYM, Boguniewicz M, Howell MD, Nomura I, Hamid QA: New insights into atopic dermatitis. J Clin Invest 2004; 113: 651-657. (Pubitemid 38544154)
42. Homey B, Steinhoff M, Ruzicka T, Leung DYM: Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 2006; 118: 178-189. (Pubitemid 43946487)
43. Galli SJ, Tsai M: Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis. J Dermatol Sci 2008; 49: 7-19. (Pubitemid 350236713)
44. Paus R, Maurer M, Slominski A, Czarnetzki BM: Mast cell involvement in murine hair growth. Dev Biol 1994; 163: 230-240. (Pubitemid 24188887)
45. Botchkarev VA: Stress and the hair follicle: exploring the connections. Am J Pathol 2003; 162: 709-712.
46. Arck PC, Handjiski B, Kuhlmei A, Peters EMJ, Knackstedt M, Peter A, Hunt SP, Klapp BF, Paus R: Mast cell deficient and neurokinin-1 receptor knockout mice are protected from stress-induced hair growth inhibition. J Mol Med 2005; 83: 386-396. (Pubitemid 41201803)